[company_age]3.0[/company_age][employees]1-10 employees[/employees][funding]seed[/funding][description]SynGenSys is a biotechnology company specializing in the design and development of synthetic promoters for the controlled expression of therapeutic genes in mammalian cells. Founded in 2021, the company leverages its deep understanding of mammalian gene regulation and computational tools to identify and engineer synthetic promoters with desired expression profiles. SynGenSys boasts a team of experienced scientists and engineers with expertise in molecular biology, synthetic biology, and cell engineering. Headquartered in Sheffield, United Kingdom, the company also operates a research and development facility in Cambridge, Massachusetts.[/description][ps]Design and development of synthetic promoters for the controlled expression of therapeutic genes in mammalian cells.[/ps]